Related Experiment Video
Updated: Jul 3, 2026
09:16
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
[Polyarteritis Nodosa, a vanishing vasculitis since its main cause has been identified]
1Klinik und Poliklinik für Nephrologie und Hypertonie, Inselspital, Bern. felix.frey@insel.ch
Therapeutische Umschau. Revue Therapeutique
|July 16, 2008
Summary
Polyarteritis nodosa, a vasculitis, is often caused by hepatitis B infection. Targeting the hepatitis B virus, rather than just symptoms, has improved treatment and reduced disease prevalence through vaccination.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Polyarteritis nodosa (PN) is a serious form of vasculitis.
- Historically, PN treatment focused on immunosuppression.
- The link between PN and hepatitis B virus (HBV) was a significant discovery.
Observation:
- HBV infection can trigger an exaggerated immune response leading to PN.
- Identifying HBV as a cause shifted treatment strategies.
- Hepatitis B vaccination has demonstrably reduced PN incidence.
Findings:
- Effective PN management involves targeting the underlying infectious agent (HBV).
- For PN cases not associated with HBV, symptomatic immunosuppressive therapy remains the primary approach.
- Research into autoimmune diseases should prioritize etiological factors.
Implications:
- This case study highlights the importance of identifying causative agents in autoimmune diseases.
- Focusing on etiological factors offers more effective treatment and prevention strategies than solely managing symptoms.
- Vaccination and etiological treatments represent a paradigm shift in managing certain autoimmune-related vasculitides.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...